Athembio

At AthemBio, we are solving the toughest challenges in bioprocessing, starting with the most critical: the high cost of biologics. Too many promising therapies are discontinued due to excessive manufacturing expenses, and even biosimilars often fail to provide significant cost relief. We are a private company headquartered in Research Triangle Park, North Carolina, with a mission to empower the future of bioprocessing and healthcare accessibility. We achieve this by providing groundbreaking, next-generation single-use bioprocessing technology solutions. Our innovative platforms are engineered to reduce the number of manufacturing steps, enable the manufacturing of challenging materials, and deliver significant cost reductions while improving the speed and quality of therapeutics. Through collaboration with various types of global customers (start-ups, academia, large CDMOs, and biopharma leaders) we have gained a deep understanding of the real-world challenges faced in the bioprocessing industry. At AthemBio, we are committed to being your partner in achieving bioprocessing success and cost-efficiency. Through all stages (early process development, scale-up, and commercial manufacturing), we work side-by-side with our customers every step of the way. Our team is dedicated to helping customers overcome challenges, accelerate progress, and achieve reliable, reproducible results. With AthemBio, you can expect proactive support, responsive communication, and a shared commitment to delivering life-saving therapies to patients around the world—affordably. Let us help you turn your innovation into impact – faster, more efficiently, and together.